Print this page

[43] Non-current financial assets 

XLS

 

 

 

€ million

Dec. 31, 2013

Dec. 31, 2012

Investments

19.2

16.1

Investments in associates and other companies

34.3

27.3

Securities – Available-for-sale financial assets

3.8

5.3

Securities – Held to maturity investments

30.0

Assets from derivatives (financial transactions)

4.7

0.4

Loans and other non-current financial assets

15.8

18.0

 

77.8

97.1

Unconsolidated investments and the investments in associates and other companies were classified as “available for sale”. Thereof investments with a carrying amount of € 52.3 million (2012: € 41.8 million) were subsequently measured at cost since their market value could not be determined.

In 2013, impairment losses were recognized for unconsolidated investments of € 1.4 million (2012: € 5.0 million) and for available-for-sale financial assets of € 4.1 million (2012: € 0.1 million). These were recorded in the income statement under other operating expenses.

Moreover, fair value adjustments of € 1.8 million (2012: € 0.4 million) were made on available-for-sale financial assets and recognized in equity.

© Merck KGaA, Darmstadt, Germany, Last Update 2014/03/06